Down-regulation of argininosuccinate lyase induces hepatoma cell apoptosis through activating Bax signaling pathway
- PMID: 32042869
- PMCID: PMC6997574
- DOI: 10.1016/j.gendis.2018.11.003
Down-regulation of argininosuccinate lyase induces hepatoma cell apoptosis through activating Bax signaling pathway
Abstract
Argininosuccinate lyase (ASL) plays an important role in the hepatic urea cycle, and can catalyze the reversible reaction of argininosuccinate to arginine and fumarate. However, the function of ASL in hepatocellular carcinoma (HCC) is not fully understood. In this study, we found that ASL expression was frequently upregulated in HCC tissues and HCC cell lines. Knock down of ASL inhibited cell proliferation and induced apoptosis in HCC cells. Mechanistic studies revealed the BCL2-associated X protein (Bax) signaling pathway which determines cancer cell apoptosis was regulated by ASL. Moreover, the depletion of Bax restored the inhibition of cell growth and reduced apoptosis initiated by ASL silencing. Together, the study demonstrated that ASL regulated HCC cell growth and apoptosis by modulating Bax signaling. Thus, the therapeutic targeting of ASL may offer options for HCC treatment.
Keywords: ASL; Apoptosis; Bax; HCC; Proliferation.
© 2018 Chongqing Medical University. Production and hosting by Elsevier B.V.
Figures




Similar articles
-
Reduced expression of argininosuccinate lyase is closely associated with postresectional survival in hepatocellular carcinoma: an immunohistochemistry study of 61 cases.Appl Immunohistochem Mol Morphol. 2012 Dec;20(6):602-6. doi: 10.1097/PAI.0b013e318250c814. Appl Immunohistochem Mol Morphol. 2012. PMID: 22531684
-
Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells.Oncol Rep. 2017 Feb;37(2):969-978. doi: 10.3892/or.2016.5334. Epub 2016 Dec 23. Oncol Rep. 2017. PMID: 28035420 Free PMC article.
-
Attenuation of argininosuccinate lyase inhibits cancer growth via cyclin A2 and nitric oxide.Mol Cancer Ther. 2013 Nov;12(11):2505-16. doi: 10.1158/1535-7163.MCT-12-0863. Epub 2013 Aug 26. Mol Cancer Ther. 2013. PMID: 23979921
-
Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.J Hepatol. 2013 Oct;59(4):830-41. doi: 10.1016/j.jhep.2013.04.031. Epub 2013 May 7. J Hepatol. 2013. PMID: 23665184 Review.
-
Argininosuccinate neurotoxicity and prevention by creatine in argininosuccinate lyase deficiency: An in vitro study in rat three-dimensional organotypic brain cell cultures.J Inherit Metab Dis. 2019 Nov;42(6):1077-1087. doi: 10.1002/jimd.12090. Epub 2019 Apr 14. J Inherit Metab Dis. 2019. PMID: 30907007 Review.
Cited by
-
Amino Acid-Metabolizing Enzymes in Advanced High-Grade Serous Ovarian Cancer Patients: Value of Ascites as Biomarker Source and Role for IL4I1 and IDO1.Cancers (Basel). 2023 Jan 31;15(3):893. doi: 10.3390/cancers15030893. Cancers (Basel). 2023. PMID: 36765849 Free PMC article.
-
Serum urea concentration and risk of 16 site-specific cancers, overall cancer, and cancer mortality in individuals with metabolic syndrome: a cohort study.BMC Med. 2024 Nov 15;22(1):536. doi: 10.1186/s12916-024-03758-5. BMC Med. 2024. PMID: 39548477 Free PMC article.
References
-
- Budny A., Kozlowski P., Kaminska M. Epidemiology and risk factors of hepatocellular carcinoma. Polski merkuriusz lekarski – Organ Polskiego Towarzystwa Lekarskiego. 2017;43(255):133–139. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials